YOUR BUSINESS AUTHORITY
Springfield, MO
Swiss pharmaceutical company Novartis AG plans to buy French drugmaker Advanced Accelerator Applications for $3.9 billion.
Advanced Accelerator Application develops molecular nuclear medicine, including Lutathera. It was approved in Europe in September to fight gastroenteropancreatic neuroendocrine tumors.
The deal was approved by Advanced Accelerator Application's board of directors.
Read more from TheStreet.
Shortly after getting married, Amos and Shelby Hale became first-time business owners with the July 10 launch of 9 Lives Tavern in downtown Ozark.